Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JUAN BAUTISTA IRIBARREN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1720283336
CMS profile
123262
Location
BEAUMONT, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$77,573.81

141 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–141 of 141 matching records. This page contains 41 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JUAN BAUTISTA IRIBARREN

NPI 1720283336 · CMS profile ID 123262

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

BEAUMONT, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–141 of 141 matching records. This page contains 41 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1720283336?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JUAN BAUTISTA IRIBARREN, NPI 1720283336, CMS profile ID 123262. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–141 of 141 matching records. This page contains 41 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1720283336?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JUAN BAUTISTA IRIBARREN, NPI 1720283336, CMS profile ID 123262. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–141 of 141 matching records. This page contains 41 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1720283336?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JUAN BAUTISTA IRIBARREN, NPI 1720283336, CMS profile ID 123262, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–141 of 141 matching records. This page contains 41 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1720283336?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

141 matching records · $77,573.81 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 141 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–141 of 141.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Insmed, Inc. $3.3005/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978782999 CMS
GENZYME CORPORATION $30.4105/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140937 CMS
Actelion Pharmaceuticals US, Inc. $26.8305/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988771347 CMS
GlaxoSmithKline, LLC. $25.4504/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003243657 CMS
Gilead Sciences, Inc. $18.5604/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025872491 CMS
Insmed, Inc. $18.1204/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978820745 CMS
Insmed, Inc. $7.3704/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978820753 CMS
GENZYME CORPORATION $23.4003/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140921 CMS
Insmed, Inc. $2.1603/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978791611 CMS
GENZYME CORPORATION $1,516.0003/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140929 CMS
AstraZeneca Pharmaceuticals LP $16.6803/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011723377 CMS
GlaxoSmithKline, LLC. $3,900.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003242873 CMS
Boston Scientific Corporation $13.6003/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022208931 CMS
Gilead Sciences, Inc. $16.6803/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025940387 CMS
GlaxoSmithKline, LLC. $9.5203/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003242885 CMS
GlaxoSmithKline, LLC. $3,900.0003/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003231847 CMS
GlaxoSmithKline, LLC. $3,900.0003/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003241313 CMS
Insmed, Inc. $26.8503/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978782985 CMS
Actelion Pharmaceuticals US, Inc. $19.9903/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988771343 CMS
Actelion Pharmaceuticals US, Inc. $0.4703/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988771345 CMS
GENZYME CORPORATION $20.5703/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140917 CMS
GlaxoSmithKline, LLC. $3,900.0003/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003242865 CMS
AstraZeneca Pharmaceuticals LP $19.2802/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014510541 CMS
Inspire Medical Systems, Inc. $20.8902/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058800651 CMS
GlaxoSmithKline, LLC. $3,900.0002/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003241329 CMS
Philips Electronics North America Corporation $14.4702/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1024061321 CMS
Actelion Pharmaceuticals US, Inc. $22.2202/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988771349 CMS
Actelion Pharmaceuticals US, Inc. $1.0802/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988771351 CMS
GlaxoSmithKline, LLC. $3,900.0002/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003231835 CMS
GlaxoSmithKline, LLC. $5.7902/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003242889 CMS
Insmed, Inc. $6.7102/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978782993 CMS
GENZYME CORPORATION $24.6202/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140901 CMS
GlaxoSmithKline, LLC. $1,300.0002/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003242913 CMS
Insmed, Inc. $5.7801/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978795475 CMS
Insmed, Inc. $22.5701/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978795477 CMS
Regeneron Healthcare Solutions, Inc. $6.1101/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999221659 CMS
AstraZeneca Pharmaceuticals LP $71.6201/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011480273 CMS
AstraZeneca Pharmaceuticals LP $16.8801/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970387 CMS
GENZYME CORPORATION $26.2001/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140889 CMS
GENZYME CORPORATION $45.1001/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050140905 CMS
Actelion Pharmaceuticals US, Inc. $25.1001/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988771353 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $89,341.32 116
PY2020 $111,946.19 121
PY2021 $71,457.16 91
PY2022 $81,684.96 90
PY2023 $77,573.81 141
PY2024 $259,635.85 231
PY2025 $223,764.07 257

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $2,546.52 3
PY2024 Principal investigator $18,580.11 41
PY2023 Principal investigator $39,073.64 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Dompe Farmaceutici S.p.A. $7.55 12/01/2025 Covered Recipient Teaching Hospital
Baptist Beaumont Hospital
Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory Distress Syndrome (RESPIRATIO) No dispute reported 06/30/2026 1248395860
Principal investigator 1 Dompe Farmaceutici S.p.A. $1,594.67 07/30/2025 Covered Recipient Teaching Hospital
Baptist Beaumont Hospital
Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory Distress Syndrome (RESPIRATIO) No dispute reported 06/30/2026 1248395856
Principal investigator 1 Dompe Farmaceutici S.p.A. $944.30 07/30/2025 Covered Recipient Teaching Hospital
Baptist Beaumont Hospital
Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory Distress Syndrome (RESPIRATIO) No dispute reported 06/30/2026 1248395858